A bitter pill for ARMUNIA: ARYUNA clears confusion test as General Court holds firm on pharma attention (T‑591/24) By Wissam Bentazar on Wednesday, July 08, 2026 average consumer EU General Court EU trademark EUIPO pharmaceuticals Wissam Bentazar +
[Guest Post] CJEU weighs in on supplementary protection certificates in Merck v Teva/Clonmel decision By Jocelyn Bosse on Thursday, February 13, 2025 CJEU Finland invention Ireland Jocelyn Bosse pharmaceuticals SPCs Teva test +
Australian Full Court clarifies the meaning of "first approval" for the purpose of patent term extension (PTE) By Dr Rose Hughes on Tuesday, April 19, 2022 Australia patent term extension patents pharmaceuticals PTEs Rose Hughes +
‘Competition law in the pharmaceutical sector’ conference returns with IPKat readers’ discounted fee By Eleonora Rosati on Tuesday, October 26, 2021 competition law events pharma pharmaceuticals +
New decision of the Swedish Patent and Market Court of Appeal addresses interface between new safety regulation for packaging of pharmaceuticals and parallel imports By Frantzeska Papadopoulou on Tuesday, October 01, 2019 #IPKat falsified medicines directive Frantzeska Papadopoulou medicines parallel imports patents pharmaceuticals Sweden trade marks +
Public procurement of pharmaceuticals and the patent system, the first date of a stormy relationship? By Frantzeska Papadopoulou on Thursday, October 04, 2018 IFMPA patents pharmaceuticals public procurement WIPO +
Surveying the scene - passing off & surveys By Rosie Burbidge on Saturday, February 17, 2018 asthma Birss colour get up GSK high court interflora Passing off pharmaceuticals purple sandoz Seretide shape survey Survey evidence trade mark trade marks trademark +
An Improved Improver? - Part 3 By Stephen on Thursday, August 10, 2017 direct patent infringement doctrine of equivalents indirect patent infringement lord neuberger patents pharmaceuticals Supreme Court +
Intellectual Property Challenges in the Bio-Pharmaceutical Field By Mike Mireles on Wednesday, May 04, 2016 biotechnology couzzo speed technologies dri capital inter partes review myriad patents pharmaceuticals price regulation royalty pharma securitization +